Top story

Building Confidence in African Traditional Medicines

NAIROBI, 31 August 2026 — African traditional medicines remain an integral part of society and healthcare, but unlocking their full potential requires stronger quality assurance, safety monitoring, scientific evidence, accurate dosing, standardised production and …

Read full story

Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA)

PharmaProLearn News
Wed, 29 Jan 2025
Read more

Saol Therapeutics Announces FDA Acceptance of New Drug Application for SL1009 for Treatment of Pyruvate Dehydrogenase Complex Deficiency

PharmaProLearn News
Tue, 28 Jan 2025
Read more

Drug Safety Communication: Copaxone, Glatopa (glatiramer acetate) - FDA Adds Boxed Warning About a Rare but Serious Allergic Reaction Called Anaphylaxis

PharmaProLearn News
Wed, 22 Jan 2025
Read more

Tris Pharma Announces Positive Results from ALLEVIATE-1 Phase 3 Clinical Trial of Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of Moderate-to-Severe Acute Pain

PharmaProLearn News
Wed, 22 Jan 2025
Read more

Zydus Announces USFDA Orphan Drug Designation to Usnoflast for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

PharmaProLearn News
Wed, 22 Jan 2025
Read more

FDA Investigating Serious Risk of Hematologic Malignancy Following Skysona (elivaldogene autotemcel)

PharmaProLearn News
Wed, 27 Nov 2024
Read more

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

PharmaProLearn News
Wed, 27 Nov 2024
Read more

Soleno Therapeutics Announces FDA Extension of Review Period for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome

PharmaProLearn News
Tue, 26 Nov 2024
Read more

Mxbbb Issues Voluntary Nationwide Recall of Umary Acid Hyaluronic Due to the Presence of Diclofenac and Omeprazole

PharmaProLearn News
Wed, 20 Nov 2024
Read more